Eliminating commercial barriers between groundbreaking science and U.S. market traction

Resources for biotech, medtech, and digital health companies—especially international and university-driven innovations—navigating U.S. commercialization, from product strategy and evidence generation to emerging policy and market access.

Subscribe to Newsletter

Background

14+ years across US payers (Humana), precision medicine (McKesson/Ontada), and RWE platforms (Komodo Health, Clarify). MBA Chicago Booth, MPH King's College London. Full bio on LinkedIn

Select Initiatives:

  • Board Advisor, Wharton Penn Biotech Conference 2025

  • Investor & Advisor, Gaingels

Get in Touch

For speaking inquiries, advisory opportunities, or to continue the conversation: Schedule a call.